# Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer

> **NCT00290966** · PHASE2,PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 610 (—)

## Conditions studied

- Stomach Neoplasm

## Interventions

- **DRUG:** XRP6976

## Key facts

- **NCT ID:** NCT00290966
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** —
- **Final completion:** 2003-05
- **Target enrollment:** 610 (—)
- **Last updated:** 2009-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00290966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00290966, "Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00290966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*